IND (Investigation of New Drug ) application

For any suggestion mail at "[email protected]" Insta: dearpharmasquare The IND application is submitted by the company or research group responsible for developing the drug to the FDA. An Investigational New Drug is a drug developed by a sponsor that is ready for clinical trials on humans. developing the drug to the FDA. The FDA reviews IND applications and decides whether they are safe for companies to progress the clinical trial stage. The IND application contains information in three broad areas: ●Animal Pharmacology and Toxicology Studies ●Manufacturer Information ●Clinical Protocols and Investigator Information Type of IND: ○ COMMERCIAL IND ○NON- COMMERCIAL IND